Singapore markets closed

MannKind Corporation (MNKD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.0900+0.1000 (+3.34%)
At close: 04:00PM EDT
3.1100 +0.02 (+0.65%)
After hours: 07:13PM EDT
Full screen
Loading interactive chart…
  • Motley Fool

    MannKind Corporation (MNKD) Q2 2022 Earnings Call Transcript

    As a reminder, this call is being recorded on August 9, 2022, and will be available for playback on the MannKind Corporation website shortly after the conclusion of this call until August 23, 2022. Joining us today from MannKind are Chief Executive Officer Michael Castagna and Chief Financial Officer Steven Binder.

  • Zacks

    MannKind (MNKD) Reports Q2 Loss, Tops Revenue Estimates

    MannKind (MNKD) delivered earnings and revenue surprises of -22.22% and 15.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Motley Fool

    Why Shares of MannKind Corporation Climbed 10.4% on Monday

    What happened Shares of MannKind Corporation (NASDAQ: MNKD), a biotech company that specializes in finding therapies for endocrine and orphan lung diseases, rose 10.4% on Monday. The stock closed at $3.